CHICAGO (MedPage Today) —Multiple myeloma patients whose disease is not controlled by lenalidomide (Revlimid) or bortezomib (Velcade) appear to respond to treatment with pomalidomide (Actimid) plus dexamethasone,researchers reported here.
MedPageToday.com –medical news plus CME for physicians












































